{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T23:53:23Z","timestamp":1675382003964},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/mbc.0000000000000421","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T01:52:56Z","timestamp":1452909176000},"page":"205-209","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of rotation thromboelastometry parameters in patients with essential thrombocythemia at diagnosis and after hydroxyurea therapy"],"prefix":"10.1097","volume":"27","author":[{"given":"Jacek","family":"Treli\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Oko\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Robak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Chojnowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210203","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002779900136","article-title":"Myeloproliferative disorders: complications, survival and causes of death.","volume":"79","author":"Brodmann","year":"2000","journal-title":"Ann Hematol"},{"key":"R2-17-20210203","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C","article-title":"Life expectancy of patients with chronic nonleukemic myeloproliferative disorders.","volume":"67","author":"Rozman","year":"1991","journal-title":"Cancer"},{"key":"R3-17-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"R4-17-20210203","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis.","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"key":"R5-17-20210203","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications.","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"},{"key":"R6-17-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.thromres.2014.01.011","article-title":"Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis.","volume":"133","author":"Trelinski","year":"2014","journal-title":"Thromb Res"},{"key":"R7-17-20210203","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"R8-17-20210203","first-page":"1","article-title":"Mechanism of action of hydroxyurea.","volume":"19","author":"Yarbro","year":"1992","journal-title":"Semin Oncol"},{"key":"R9-17-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V98.1.108","article-title":"Plateletpolymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin.","volume":"98","author":"Piccardoni","year":"2001","journal-title":"Blood"},{"key":"R10-17-20210203","first-page":"2593","article-title":"Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug J Thromb H","volume":"4","author":"Maugeri","year":"2006","journal-title":"aemost"},{"key":"R11-17-20210203","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.leu.2404914","article-title":"Proposed criteria for the diagnosis of postpolycythemia vera and postessential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.","volume":"22","author":"Barosi","year":"2008","journal-title":"Leukemia"},{"key":"R12-17-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2257.2005.00681.x","article-title":"Thrombelastographythromboelastometry.","volume":"27","author":"Luddington","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"R13-17-20210203","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mbc.0000169225.31173.19","article-title":"Multicentre investigation on reference ranges for ROTEM thromboelastometry.","volume":"16","author":"Lang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R14-17-20210203","first-page":"S20","article-title":"Possibilities and limitations of thrombelastometry-graphy.","volume":"26","author":"Lang","year":"2006","journal-title":"Hamostaseologie"},{"key":"R15-17-20210203","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000175153","article-title":"Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders.","volume":"36","author":"Marchetti","year":"2008","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R16-17-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.thromres.2013.01.009","article-title":"Impact of changes in haematocrit level and platelet count on thromboelastometry parameters.","volume":"131","author":"Nagler","year":"2013","journal-title":"Thromb Res"},{"key":"R17-17-20210203","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1213\/ane.0b013e3181966675","article-title":"The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.","volume":"108","author":"Lang","year":"2009","journal-title":"Anesth Analg"},{"key":"R18-17-20210203","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/bja\/87.2.246","article-title":"Isolated reduction of haematocrit does not compromise in vitro blood coagulation.","volume":"87","author":"Iselin","year":"2001","journal-title":"Br J Anaesth"},{"key":"R19-17-20210203","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"key":"R20-17-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajh.23895","article-title":"Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.","volume":"90","author":"Tefferi","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000000421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:24:19Z","timestamp":1620959059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201603000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000421","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}